Do entities conducting clinical trials definitely need to conclude additional compulsory third-party liability insurance agreements under the recently amended Medical Professions Act?

| Wednesday March 17th, 2021

In our last post on this subject (available at  we gave an overview of the most important changes to the law on conducting...
read more »

New insurance obligations, rules for the participation of minors and penalty regulations – overview of the most important changes in respect of running medical experiments

| 21/01/2021

As of 1 January 2021, changes in the regulations regarding medical experiments, introduced in amendments to the Medical Profession Act, have entered into force. Asa reminder, we would like to point...
read more »

“The only one of its kind on the market, antiviral properties” – advertising medicinal products in the age of the pandemic

| 28/05/2020

The advertising of medicinal products is strictly regulated. During a pandemic, responsible entities should take extra care when producing advertising content. It may turn out that previously...
read more »
I agree X

We use cookies to enhance the functionality of the website by storing your preferences. By continuing to use this site, you accept these cookies.